Sunrest Lifescience Limited
ListedSMEEmerging SME Services · NSE
Incorporated in 2017, Sunrest Lifescience Limited offers a wide range of healthcare and personal care products, including capsules, tablets, syrup, ointment, gel, mouthwash, solution, suspension, dry powders, and toothpaste. Its portfolio covers medicines across multiple therapeutic categories like anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-protozoal, anti-histamine, anti-hypertensive, cosmetics, anti-parasitic, multivitamin, multimineral, nutraceutical, and anti-inflammatory. With 18 registered trademarks covering 32 products, Sunrest Lifescience is focused on delivering high-quality and effective formulations to its customers.
Price Band
₹84
Issue Size
₹10.85 Cr
Lot Size
1600 shares
GMP
₹5
+6.0%
Est. Listing
₹89
at current GMP
Subscribed
47.51x
overall
Open
7 Nov 2023
Close
9 Nov 2023
Allotment
15 Nov 2023
Refund
16 Nov 2023
Demat Credit
17 Nov 2023
Listing
20 Nov 2023
Last updated 12 days ago
Overall Subscription
47.51x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
29.28x
High Net-Worth
Retail (RII)
65.74x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| NIB | 612,800 | 17,944,000 | 29.28x |
| RETAIL | 612,800 | 40,286,400 | 65.74x |
| Total | 1,225,600 | 58,230,400 | 47.51x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 283 | 18,604 | 65.74x |
| HNIs (10L +) | 2 | 59 | 29.28x |
| HNIs (2-10L) | 9 | 264 | 29.28x |
| Total Applications | 294 | 18,927 | 64.38x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Sunrest Lifescience Limited Public Issue & Market Profile
Sunrest Lifescience Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹10.85 Crores. The shares are offered at a price band of ₹84 to ₹84 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1600 shares (approx. ₹1,34,400 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Skyline Financial Services Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-11-17, while un-allotted funds or UPI block mandates will be released on 2023-11-16.
Frequently Asked Questions
What is Sunrest Lifescience Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Sunrest Lifescience Limited IPO is ₹5 per equity share. Based on the upper price band of ₹84 to ₹84 per equity share, the estimated listing price is ₹89 (+6.0% expected listing gain).
What is the expected profit per lot for Sunrest Lifescience Limited IPO?
With a lot size of 1600 shares and current GMP of ₹5, the expected profit per application lot is approx ₹8,000 (+6.0% gain). Minimum application cost is approx ₹1,34,400.
What is the issue size and price band for Sunrest Lifescience Limited IPO?
The Sunrest Lifescience Limited IPO aggregate issue size is ₹10.85 Crores with an equity price band set at ₹84 to ₹84 per equity share. The retail lot size is 1600 shares requiring a minimum capital outlay of approx. ₹1,34,400.
How can I check Sunrest Lifescience Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 47.51x (Retail: 65.74x, QIB: 0.00x, NII: 29.28x). You can track live multiples directly on our dedicated subscription page.
Where and when will Sunrest Lifescience Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Skyline Financial Services Private Limited) and the BSE status verification website on or around 2023-11-15. Investors can verify status using PAN card or application number.
When is the listing date for Sunrest Lifescience Limited IPO?
Sunrest Lifescience Limited shares are scheduled to list on NSE on 2023-11-20.